The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Your guide to what the 2024 US election means for Washington and the world Prices ... in Europe by market capitalisation. Its shares dropped 4.3 per cent to DKr575.6 ($79.33). The group of drugs ...

Industry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.

(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from ...

but those drugs are too expensive and should be lowered in price," Becerra said in an interview with CNN. Sign up here. A look at the day ahead in European and global markets from Wayne Cole.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

The US plans to slash the price it pays for the Novo Nordisk A ... of a higher dose of Wegovy disappointed investors and European drug regulators said they were investigating cases of a rare ...

State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...

Drug price discounting is becoming more frequent and complex as industry and health care systems struggle to balance access and affordability. Leela Barham considers the pros and cons of keeping ...

Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.

BEIJING: China's finance ministry on Tuesday (Feb 4) announced a package of tariffs on a range of US products in an immediate ...